Epidemiology of methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2003

被引:17
作者
Hedin, Goran [1 ]
Fang, Hong [1 ]
机构
[1] Karolinska Univ Hosp, Dept Clin Microbiol, SE-14186 Stockholm, Sweden
关键词
FIELD GEL-ELECTROPHORESIS; PANTON-VALENTINE LEUKOCIDIN; REAL-TIME PCR; VANCOMYCIN SUSCEPTIBILITY; REDUCED SUSCEPTIBILITY; INFECTIONS; EMERGENCE; MRSA; POPULATION; PREVALENCE;
D O I
10.1089/mdr.2007.760
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The number of patients infected/colonised by methicillin-resistant Staphylococcus aureus (MRSA) began to rise in southern Stockholm in 2000. The present study is an analysis based on information concerning the 181 newly detected patients with MRSA during 2000-2003, results of antibiotic susceptibility tests, molecular epidemiologic typing with pulsed-field gel electrophoresis and multilocus sequence typing, and detection of Panton-Valentine leukocidin genes. No single MRSA clone was causing the epidemic situation. Instead a number of rather small, limited outbreaks took place, caused by different MRSA clones and often starting from a patient who had acquired MRSA abroad. Different clones were found in the hospitals and in the community. Sequence types (STs) 22, 239, 247, 8, and 45 were the predominant clones causing outbreaks among hospitalized patients. Most isolates belonging to these clones were multiply resistant to antimicrobial agents. Suspected glycopeptide heteroresistance was found in isolates belonging to STs 247, 239, and 592. In the community, the most widely spread MRSA was ST 80, although isolates belonging to STs 8, 30, 59, and 150 were also observed. The community-acquired isolates were usually not multiresistant. In contrast to the clones transmitted in hospitals, most community-acquired MRSA clones harbored the PVL genes, except for isolates belonging to ST 150 spread in the community among homeless people with foot ulcers and wounds.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 43 条
[1]   Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin [J].
Ariza, J ;
Pujol, M ;
Cabo, J ;
Peña, C ;
Fernández, N ;
Liñares, J ;
Ayats, J ;
Gudiol, F .
LANCET, 1999, 353 (9164) :1587-1588
[2]   Multilocus sequence typing of methicillin-resistant Staphylococcus aureus from an area of low endemicity by real-time PCR [J].
Berglund, C ;
Mölling, P ;
Sjöberg, L ;
Söderquist, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4448-4454
[3]   Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital [J].
Björholt, I ;
Haglind, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (09) :688-695
[4]   Epidemiological validation of pulsed-field gel electrophoresis patterns for methicillin-resistant Staphylococcus aureus [J].
Blanc, DS ;
Struelens, MJ ;
Deplano, A ;
De Ryck, R ;
Hauser, PM ;
Petignat, C ;
Francioli, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3442-3445
[5]   MULTIPLEX POLYMERASE CHAIN-REACTION FOR DETECTION OF GENES FOR STAPHYLOCOCCUS-AUREUS THERMONUCLEASE AND METHICILLIN RESISTANCE AND CORRELATION WITH OXACILLIN RESISTANCE [J].
BRAKSTAD, OG ;
MAELAND, JA ;
TVETEN, Y .
APMIS, 1993, 101 (09) :681-688
[6]  
BURMAN LG, 1995, EPID AKTUELLT, V2, P6
[7]   Glycopeptide resistance in Staphylococcus aureus [J].
Chadwick, PR ;
Wooster, SL .
JOURNAL OF INFECTION, 2000, 40 (03) :211-217
[8]   Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco [J].
Charlebois, ED ;
Bangsberg, DR ;
Moss, NJ ;
Moore, MR ;
Moss, AR ;
Chambers, HF ;
Perdreau-Remington, F .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) :425-433
[9]  
*CLIN LAB STAND I, 2005, 15 INF S
[10]   Community-acquired methicillin-resistant Staphylococcus aureus infections in France:: Emergence of a single clone that produces Panton-Valentine leukocidin [J].
Dufour, P ;
Gillet, Y ;
Bes, M ;
Lina, G ;
Vandenesch, F ;
Floret, D ;
Etienne, J ;
Richet, H .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) :819-824